Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The ability of hydroxocobalamin to rapidly scavenge and detoxify cyanide by chelation has resulted in several acute animal and human studies using systemic hydroxocobalamin doses at suprapharmacological doses as high as 140 mg/kg to support its use as an intravenous (IV) treatment for cyanide exposure
This study was designed to test specific interest in and buy-in of the various marketing strategies, collaboration, economy of scale, and special event exposure for all potential participants
Research focuses on its role in actin regulation, cell migration, and the promotion of new blood-vessel formation
Injectable vials: Indicated for severe cases with a dosage of 1 vial per day until symptoms begin to improve
Injecting too deeply can increase discomfort
Results were considered statistically significant when the p-value was 0.05 for all tests
US$ 27.07
US$ 27.46
US$ 22.14
US$ 22.39
US$ 24.40
US$ 20.99
US$ 22.96
US$ 27.89
US$ 28.69
US$ 23.54
US$ 29.74